| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Krystal Biotech, Inc. | Chief Accounting Officer | Common Stock | 19,318 | $3,462,752 | $179.25 | 28 Feb 2025 | Direct |
| Krystal Biotech, Inc. | Chief Accounting Officer | Performance Stock Units | 7,500 | $1,322,925 | $176.39 | 28 Feb 2025 | Direct |
| Krystal Biotech, Inc. | Chief Accounting Officer | Stock Option (Right to Buy) | 10,000 | $819,100 | $81.91 | 28 Feb 2025 | Direct |
| Krystal Biotech, Inc. | Chief Accounting Officer | Restricted Stock Units | 2,200 | $388,058 | $176.39 | 28 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | 26 Feb 2025 | 10 | -$1,568,608 | 4 | Chief Accounting Officer | 28 Feb 2025, 19:01 |
| KRYS | Krystal Biotech, Inc. | 28 Feb 2024 | 21 | -$889,034 | 4 | Chief Accounting Officer | 01 Mar 2024, 20:20 |
| KRYS | Krystal Biotech, Inc. | 28 Feb 2024 | 32 | -$768,756 | 4 | Chief Accounting Officer | 01 Mar 2024, 20:16 |
| KRYS | Krystal Biotech, Inc. | 26 Feb 2024 | 9 | -$825,261 | 4 | Chief Accounting Officer | 28 Feb 2024, 21:33 |
| KRYS | Krystal Biotech, Inc. | 22 Jan 2024 | 3 | -$194,350 | 4 | Chief Accounting Officer | 24 Jan 2024, 17:44 |
| KRYS | Krystal Biotech, Inc. | 19 May 2023 | 21 | -$2,673,990 | 4 | Chief Accounting Officer | 23 May 2023, 16:23 |
| KRYS | Krystal Biotech, Inc. | 26 Feb 2023 | 3 | -$168,218 | 4 | Chief Accounting Officer | 28 Feb 2023, 17:43 |
| KRYS | Krystal Biotech, Inc. | 26 Feb 2022 | 2 | -$92,000 | 4 | Chief Accounting Officer | 01 Mar 2022, 20:25 |